Mobile technology is helping those with acute diabetes in Germany manage their illness more effectively so that long-term complications associated with the illness can be treated earlier. A new telemedicine solution called DiabCareOnline from Germany's Ontaris, being highlighted at this week's MEDICA (Hannover, 18-21 November), combines a blood glucose meter and patient diary with the Anoto digital pen and a mobile phone to enable faster communication of patient data. The new system is already being rolled out to diabetes patients at Bethesda Hospital in Stuttgart, Germany.
From the patient's point of view, the monitoring process remains virtually the same as before: they measure their blood sugar with the meter and fill in their patient diaries. But instead of a normal pen they use the Anoto digital pen, which automatically captures their handwritten notes and converts them into digital format.
The digital pen looks like a ballpoint pen. A tiny infrared camera at its tip tracks its movements relative to a grey dot pattern printed on the pages of the patient diary, recording and storing what is being written.
Both the glucose meter (Accu Chek Aviva from Roche Diagnostics) and the Anoto digital pen are Bluetooth-enabled. This enables results and diary entries to be transmitted daily via a mobile phone to the patient's electronic health record. The readings are then automatically compared with the patient's specific blood sugar targets. If this analysis reveals critical discrepancies, the consultant in charge of the patient's treatment can intervene more rapidly than previously possible.
This fast response can make a significant difference to the patient's well-being as acute health issues can be addressed much more quickly. With much of the data analysis being handled remotely, diabetics also do not have to attend as many appointments as before - benefitting both patients and healthcare providers.
Academic studies and experience in the field have shown digital pen and paper to be very user friendly as patients still use pen and paper, just like before. This makes the new solution suitable for diabetics of virtually all ages.
About Anoto Group
Anoto Group is the company behind and world leading in the unique technology for digital pen and paper, which enables fast and reliable transmission of handwritten text into a digital format. Anoto operates through a global partner network that focuses on user-friendly forms solutions for efficient capture, transmission and storage of data within different business segments, e.g. healthcare, bank and finance, transport and logistics and education. The Anoto Group has around 110 employees, offices in Lund (head office), Boston and Tokyo. The Anoto share is listed on NASDAQ OMX Nordic small cap list under the ticker ANOT.
For more information, visit www.anoto.com.